A
Haniyeh Khosh; Vahid SadeghiFiroozabadi; Mohsen Dehghani; Ali Khatibi; AbdolReza Nasser Moghaddasi; vahid Abdolmanafi
Abstract
Objective: This study aimed to explore the role of executive functions in moderating the relationship between medication adherence and depression among individuals with Multiple Sclerosis (MS). MS is a chronic disease that affects the central nervous system, and both cognitive and emotional factors can ...
Read More
Objective: This study aimed to explore the role of executive functions in moderating the relationship between medication adherence and depression among individuals with Multiple Sclerosis (MS). MS is a chronic disease that affects the central nervous system, and both cognitive and emotional factors can significantly influence how patients adhere to treatment plans. Medication adherence is crucial for disease management, and depression is a common comorbidity in MS patients, often complicating adherence. Understanding the relationship between depression, cognitive functions, and treatment adherence can help improve therapeutic outcomes. Method: This research was conducted as a descriptive-correlational study, targeting MS patients residing in Tehran. The sample consisted of 229 participants, selected through convenience sampling. These individuals completed three standardized questionnaires: the Beck Depression Inventory (second edition, 2005), the Executive Function Questionnaire by Najafi et al. (2014), and the Morisky Medication Adherence Scale (2008). Data collection was done through a paper-and-pencil survey method. To analyze the data, Pearson's correlation coefficient was used to examine relationships between variables, and stepwise regression analysis was performed to determine if executive functions moderate the relationship between depression and medication adherence. Results: The study found that depressive symptoms were a significant predictor of poor medication adherence in MS patients (p<0.01). This suggests that patients with higher levels of depression are more likely to struggle with adhering to their treatment regimens. Additionally, executive functions such as memory, planning, and social cognition were found to significantly predict medication adherence (p<0.01). These cognitive abilities likely help patients better manage their treatment schedules and follow medical instructions. However, the study did not find evidence supporting the role of executive functions as a moderator in the relationship between depressive symptoms and medication adherence (p>0.01). This indicates that while cognitive abilities and depression are related to medication adherence, executive functions do not appear to change the strength or direction of the relationship between depression and adherence. Conclusion: The findings highlight the importance of both depressive symptoms and executive functions in influencing medication adherence in MS patients. Given that poor medication adherence can lead to worse health outcomes, addressing both cognitive and emotional barriers to treatment is critical. Healthcare providers should consider these factors when designing treatment plans for MS patients. For example, interventions aimed at improving executive functions, such as memory and planning, as well as addressing depression, may be beneficial. By targeting both cognitive and emotional challenges, providers can help patients better adhere to their treatment regimens, which could ultimately improve disease prognosis and quality of life. Furthermore, healthcare teams should be aware of the multifaceted nature of treatment adherence and incorporate psychological and cognitive assessments into routine care to ensure comprehensive support for MS patients. In conclusion, while executive functions may not moderate the relationship between depression and adherence, they are still crucial in predicting adherence, suggesting that an integrated approach to treatment planning is vital for enhancing medication compliance in MS patients.
shahnaz gili; vahid sadeghi zavareh; Sayed Abbas Haghayegh; alireza Alizadeh ghavidel; hassan rezayi jamalloi
Abstract
Objective: The aim of this study was to compare the effectiveness of Emotion-focused therapy and Transcranial Direct Current Stimulation on anxiety and depression in heart patients in Tehran in 2019. Method: The research method is semi-experimental with a pretest-posttest design (three groups) with two ...
Read More
Objective: The aim of this study was to compare the effectiveness of Emotion-focused therapy and Transcranial Direct Current Stimulation on anxiety and depression in heart patients in Tehran in 2019. Method: The research method is semi-experimental with a pretest-posttest design (three groups) with two experimental groups and one control group. The statistical population of the study consisted of all cardiac patients in Tehran, among whom 45 were selected by available sampling method and randomly assigned in two experimental groups and one control group (15 people in each group). The Emotion-focused therapy experiment group was trained in nine 60-minute sessions and the Transcranial Direct Current Stimulation group received training during five 20-minute sessions, and the control group remained on the waiting list. The tools used in the present study included depression (Beck, Steer & Brown, 1996), and anxiety (Beck, Epstein, Brown & Esther, 1988) questionnaires, which were administered in two stages of pre-test and post-test. The analysis of data obtained from the implementation of the questionnaires were performed through SPSS-24 software in two descriptive and inferential sections (analysis of covariance). Findings: The findings showed that both interventions used in this study could significantly decrease the anxiety and depression of heart patients (p <0.05), with a greater effect of emotion- focused therapy on anxiety and depression compared to Transcranial Direct Current Stimulation. In addition, no significant difference was observed in the posttest and follow up phases (p <0.05), which indicates the stability of intervention changes. Conclusion: According to the results of this study, the treatment of Emotion-focused therapy and Transcranial Direct Current Stimulation are effective interventions in reducing anxiety and depression in heart patients, but Emotion-focused therapy was more effective.
Vahid Sadeghi Firoozabadi; Masoumeh Barani; Maryam Bakhteyari; Mahshid MehdiZadeh; Saeed Imani
Volume 6, Issue 22 , September 2017, , Pages 51-72
Abstract
Introduction: Adjuvant Psychological Therapy is a therapy derived from cognitive - behavioral therapy which specifically increases quality of life of cancer patients by means of reducing psychological distress. We decided to assessment the influence of Adjuvant Psychological Therapy on anxiety and depression ...
Read More
Introduction: Adjuvant Psychological Therapy is a therapy derived from cognitive - behavioral therapy which specifically increases quality of life of cancer patients by means of reducing psychological distress. We decided to assessment the influence of Adjuvant Psychological Therapy on anxiety and depression of patients with hematological malignancies. Method: The patients with hematological malignancies, who visited Taleqani hospital in Tehran in 2015, were the samples for the present study. Five samples were chosen in an available sampling method. Each one of them was required to answer Hospital Anxiety and Depression Scale. Results: According to the findings, Adjuvant Psychological Therapy has led to significant decrease in anxiety, depression of patients with hematological malignancies. Conclusion: Adjuvant Psychological Therapy can help decrease in psychological distress of cancer patients
A
Naser Goodarzi; Vahid Sadeghi-Firoozabadi; Reza Rostami; Abbas Rahiminezhad; Mohammad ALi Besharat; Ali Vasheghani-Farahani; Alireza Alizadeh Ghavidel; Saeed Imani
Volume 6, Issue 21 , May 2017, , Pages 29-51
Abstract
Abstract:Of cardiovascular disease, coronary artery disease (CAD) is the main cause of death in human societies leads to coronary artery bypass graft surgery (CABG) as the most common intervention. The length of hospital stay after surgery is an estimate of the success rate of surgery that cannot be ...
Read More
Abstract:Of cardiovascular disease, coronary artery disease (CAD) is the main cause of death in human societies leads to coronary artery bypass graft surgery (CABG) as the most common intervention. The length of hospital stay after surgery is an estimate of the success rate of surgery that cannot be completely explained by demographic and medical factors. Therefore, the objective of this study was to investigate the impact of psychological factors along with medical and demographic factors on the length of hospital stay after CABG surgery. In this study, 150 patients (30 females and 120 males) were selected from the convenience sampling method, among patients referred to Tehran Heart Center of Shahid Rajaie Hospital who were candidates for CABG surgery. Patients were asked to complete the questionnaire of 21 questions for anxiety- depression- stress (DASS-21). Stepwise regression analysis for psychological, medical and demographic variables showed that the most important variables to predict the length of hospital stay after surgery were anxiety and depression, diabetes and high blood pressure, age and gender. Thus, the results showed that the use of pre-operative assessment of these variables in the clinical setting, we can identify those patients for whom surgery may not be successful.
